^
Association details:
| Biomarker: | EML4-ALK L1196M |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Xalkori (crizotinib) (ALK inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer
Excerpt:
ALK Mutations Confer Resistance to Crizotinib.
DOI:
10.1097/JTO.0b013e318283dcc0
Trial ID:
